NCT05174078

Brief Summary

The purpose of this study is to investigate the effect of providing healthy foods and nutrition education on participants' body weight, blood pressure, and average blood sugar level. The healthy food offerings tested in this study will help determine which option is best to improve health outcomes among Cleveland Clinic Akron General patients with chronic conditions. Findings from this study could guide doctors in deciding on appropriate nutrition and dietitian services for Cleveland Clinic patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable obesity

Timeline
Completed

Started Feb 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 1, 2021

Completed
29 days until next milestone

First Posted

Study publicly available on registry

December 30, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

February 1, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2022

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2023

Completed
Last Updated

August 22, 2024

Status Verified

August 1, 2024

Enrollment Period

11 months

First QC Date

December 1, 2021

Last Update Submit

August 20, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in participants' body weight

    Percent weight loss

    From baseline visit (W1) to 16 week visit and at 6 months and 12 months from baseline

Secondary Outcomes (13)

  • Pre-type 2 diabetes mellitus: Change in number of medications

    From baseline visit (W1) to 16 week visit and at 6 months and 12 months from baseline

  • Pre-type 2 diabetes mellitus: Change in medication dosage

    From baseline visit (W1) to 16 week visit and at 6 months and 12 months from baseline

  • Pre-type 2 diabetes mellitus: Change in HbA1c

    From baseline visit (W1) to 16 week visit and at 6 months and 12 months from baseline

  • Type 2 diabetes mellitus: Change in number of medications

    From baseline visit (W1) to 16 week visit and at 6 months and 12 months from baseline

  • Type 2 diabetes mellitus: Change in medication dosage

    From baseline visit (W1) to 16 week visit and at 6 months and 12 months from baseline

  • +8 more secondary outcomes

Study Arms (3)

Medically-Tailored Meals (MTM)

EXPERIMENTAL

Medically-tailored meals delivered to participants' homes for 15 weeks AND one medical nutrition therapy session with a dietician + viewership of 2 to 4 nutrition education videos.

Other: Medically-tailored meals

Produce Box and Recipes

EXPERIMENTAL

Weekly produce box delivered to participants' homes and access to recipes via the internet for 15 weeks AND one medical nutrition therapy session with a dietician + viewership of 2 to 4 nutrition education videos.

Other: Produce box and recipes

Standard of Care

NO INTERVENTION

Matched controls from the same base population as participants in the intervention arms. Controls will identified from the electronic medical record (EMR).

Interventions

Medically tailored meals delivered to patients' homes for 15 weeks AND one medical nutrition therapy session with a dietician + viewership of 2 to 4 nutrition education videos.

Medically-Tailored Meals (MTM)

Weekly produce box and access to recipes via internet for 15 weeks AND one medical nutrition therapy session with a dietician + viewership of 2 to 4 nutrition education videos.

Produce Box and Recipes

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults 18 years of age or older who are patients at Akron General Center for Family Medicine
  • Have body mass index (BMI) equal to or greater that 30kg/m2 AND
  • Have at least one of the following diagnoses determined based on patients' problem list in the electronic medical record (EMR) and the international classification of diseases, 10th revision (ICD-10) codes:
  • Pre-type 2 diabetes mellitus
  • Type 2 diabetes mellitus
  • Hypertension
  • Have NOT participated in nutrition counseling at the University of Akron Nutrition Center within the past 6 months

You may not qualify if:

  • Food allergies
  • Pregnant
  • No access to internet
  • Need English language interpretation
  • Currently participating in a structured weight loss program or using weight loss medications
  • Any condition that, in the Investigator's judgement, interferes with the ability to adhere to study requirements.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cleveland Clinic Akron General

Akron, Ohio, 44307, United States

Location

Related Publications (1)

  • Kibera PW, Ofei-Tenkorang NA, Mullen C, Lear AM, Davidson EB. Food as medicine: a quasi-randomized control trial of two healthy food interventions for chronic disease management among ambulatory patients at an urban academic center. Prim Health Care Res Dev. 2023 Dec 21;24:e72. doi: 10.1017/S1463423623000579.

MeSH Terms

Conditions

ObesityHypertensionGlucose IntoleranceDiabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsVascular DiseasesCardiovascular DiseasesHyperglycemiaGlucose Metabolism DisordersMetabolic DiseasesDiabetes MellitusEndocrine System Diseases

Study Officials

  • Elliot B Davidson, MD, FAAFP

    Cleveland Clinic Akron General

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A quasi-randomized control trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 1, 2021

First Posted

December 30, 2021

Study Start

February 1, 2022

Primary Completion

December 30, 2022

Study Completion

December 30, 2023

Last Updated

August 22, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations